ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, offering promising developments across several clinical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA provides a safer, additional reliable option for therapeutic use,